Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To define in human preclinical systolic dysfunction (PSD) the actions of chronic administration of SQ BNP [nesiritide] on the left ventricular, renal and humoral function and on the integrated response to acute sodium loading.

Trial Profile

To define in human preclinical systolic dysfunction (PSD) the actions of chronic administration of SQ BNP [nesiritide] on the left ventricular, renal and humoral function and on the integrated response to acute sodium loading.

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 12 May 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Mar 2014 Primary endpoint and the number of arms (1 to 2) has been changed as reported by ClinicalTrials.gov record.
    • 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 20 Nov 2013 Status changed from active, no longer recruiting to completed.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top